A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls.

@article{Hirsch2020ACR,
  title={A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls.},
  author={Michelle S. Hirsch and Jaclyn C. Watkins},
  journal={Advances in Anatomic Pathology},
  year={2020}
}
Morphologic (ie, hematoxylin and eosin) evaluation of the Mullerian tract remains the gold standard for diagnostic evaluation; nevertheless, ancillary/biomarker studies are increasingly utilized in daily practice to assist in the subclassification of gynecologic lesions and tumors. The most frequently utilized "biomarker" technique is immunohistochemistry; however, in situ hybridization (chromogenic and fluorescence), chromosomal evaluation, and molecular analysis can also be utilized to aid in… 

Inter-component immunohistochemical assessment of proliferative markers in uterine carcinosarcoma

A combined analysis of Ki67, PCNA, MCM3, and topoIIα may provide more detailed information of cell-cycle alterations determining the heterogeneity of uterine carcinosarcomas, particularly in the sarcomatous UC component.

Vulvar angiomyofibroblastoma is molecularly defined by recurrent MTG1‐CYP2E1 fusions

It is concluded that the majority of AMFs harbour recurrent MTG1‐CYP2E1 fusion transcripts and identification of this fusion may aid in the diagnosis.

Incidence, clinical risk and prognostic factors for liver metastasis in patients with cervical cancer: a population-based retrospective study

Several potential clinical features that may be used to assess the risk and prognosis of liver metastasis in patients with cervical cancer are found and may provide clinical indications for the early identification and treatment of cervical cancer patients with hepatic metastasis.

Biomarkers and Their Implications in Alzheimer’s Disease: A Literature Review

This work aims to review the most relevant, up-to-date biomarkers and their implications in AD and finds it difficult to stratify physiological biomarkers of blood/plasma, cerebrospinal fluid, saliva/urine/hair/nail for diagnostic utility and overall understanding in the pathogenesis of neurodegeneration.

Selection of appropriate biomatrices for studies of chronic stress in animals: a review

Solid biomatrices require less frequent sampling than other biomatrix, resulting in greater time- and cost-effectiveness, greater ease of use, and fewer errors.

A preregistered vignette experiment on determinants of health data sharing behavior

The COVID-19 pandemic has spotlighted the importance of high-quality data for empirical health research and evidence-based political decision-making. To leverage the full potential of these data, a

References

SHOWING 1-10 OF 246 REFERENCES

Immunohistochemistry in Gynecologic Pathology: An Example-Based Practical Update.

  • N. BuzaP. Hui
  • Medicine
    Archives of pathology & laboratory medicine
  • 2017
Although the primary application is in the diagnostic workup, novel prognostic and predictive markers, and immunostains to screen for genetic cancer syndromes, have also been recently introduced in the field.

The utility of immunohistochemistry in the differential diagnosis of gynecologic disorders.

The utilities and pitfalls of the commonly used immunohistochemical markers in the context of overlapping morphologic features encountered in the uterus, ovaries, and fallopian tubes are discussed.

Immunohistochemistry as a diagnostic aid in cervical pathology

P63, a useful marker of squamous neoplasms within the cervix, is of value in distinguishing small cell neuroendocrine carcinoma from small cell squamous carcinoma and in confirming that a poorly differentiated carcinoma is squamous in type.

Tissue-based Immunohistochemical Biomarker Expression in Malignant Glandular Lesions of the Uterine Cervix: A Systematic Review

Biomarker expression in the discrimination of AIS from invasive adenocarcinoma, and the invasive histotypes from each other is understudied, and one or more of 15 biomarkers could have diagnostic utility.

Immunohistochemical Staining in the Distinction Between Primary Endometrial and Endocervical Adenocarcinomas: Another Viewpoint

Both site and differentiation influenced these results, with the latter more important for VIM and PR, the former for ER, both for CEA (only mEC was frequently strongly positive, and neither for the CKs studied), suggesting with about 95% accuracy in this series an endometrial origin of the tumor.

Practical issues in uterine pathology from banal to bewildering: the remarkable spectrum of smooth muscle neoplasia

Among mesenchymal tumors of the uterus, smooth muscle neoplasms are most common and endometrial stromal tumors are by far, less common than smooth muscle tumors, but can be confused with leiomyosarcomas if they are associated with an undifferentiated uterine sarcoma and the low-grade component is overlooked.

p16 Expression in the Female Genital Tract and Its Value in Diagnosis

In cervical squamous lesions, p16 is positive in most high-grade cervical intraepithelial neoplasia (CIN) and in some cases of low-grade CIN, usually those associated with high-risk HPV, whereas the more common non-HPV-associated neoplasms are largely negative or focally positive.

Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility

P53 immunohistochemistry has evolved into an accurate surrogate reflecting the underlying TP53 mutation status of a tumor, and has utility in the diagnostic workup of endometrial carcinomas. Recent
...